Form 4 for HIG Hartford (The)
Accepted 2025-02-20 00:00:00 ET · period of report 2025-02-18 · accession 0001225208-25-002053 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| DM | 2025-02-20 | 2025-02-18 | HIG | TOOKER ADIN M | Pres | M - OptEx | $25.55 | +24.6K | 36.8K | +201% | +$628.3K |
| DM | 2025-02-20 | 2025-02-18 | HIG | TOOKER ADIN M | Pres | S - Sale+OE | $112.60 | -13.6K | 43.5K | -24% | -$1.53M |
| DM | 2025-02-20 | 2025-02-18 | HIG | TOOKER ADIN M | Pres | M - OptEx | $0.00 | -24.6K | 0 | -100% | $0 |
| D | 2025-02-20 | 2025-02-18 | HIG | TOOKER ADIN M | Pres | A - Grant | $0.00 | +11.0K | 11.0K | New | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2025-02-18 | M | A | 6,732 | $48.89 | 50,413.07 | D | — | — | |
| 2 | Common | Common Stock | 2025-02-18 | S | D | 200 | $112.98 | 50,213.07 | D | — | — | (F3) Price reflected is the weighted average sale price for shares sold. The range of sales prices for the transactions reported was $112.97-$112.98 per share. The reporting person undertakes to provide, upon request by the SEC staff, the issuer, or a security holder of the issuer, full information regarding the number of shares sold at each separate price. |
| 3 | Common | Common Stock | 2025-02-18 | M | A | 6,864 | $43.59 | 43,681.07 | D | — | — | |
| 4 | Common | Common Stock | 2025-02-18 | S | D | 6,732 | $112.61 | 36,817.07 | D | — | — | (F5) Price reflected is the weighted average sale price for shares sold. The range of sales prices for the transactions reported was $112.10-$112.98 per share. The reporting person undertakes to provide, upon request by the SEC staff, the issuer, or a security holder of the issuer, full information regarding the number of shares sold at each separate price. |
| 5 | Common | Common Stock | 2025-02-18 | M | A | 10,996.79 | $0.00 | 36,817.07 | D | — | — | (F1) On February 18, 2025, the Company's Compensation and Management Development Committee certified a performance share payout based on the level of the Company's performance relative to pre-established objectives for the January 1, 2022 through December 31, 2024 performance period. The performance shares were paid in shares of the Company's common stock. |
| 6 | Common | Common Stock | 2025-02-18 | S | D | 6,664 | $112.58 | 43,549.07 | D | — | — | (F4) Price reflected is the weighted average sale price for shares sold. The range of sales prices for the transactions reported was $111.91-$112.90 per share. The reporting person undertakes to provide, upon request by the SEC staff, the issuer, or a security holder of the issuer, full information regarding the number of shares sold at each separate price. |
| 7 | Derivative | Stock Option | 2025-02-18 | M | D | 6,864 | $0.00 | 6,864 | D | $43.59 · — to 2026-03-01 | 6,864 Common Stock | (F7) The options became fully exercisable on March 1, 2019, the third anniversary of the grant date. |
| 8 | Derivative | Performance Shares | 2025-02-18 | A | A | 10,996.79 | $0.00 | 10,996.79 | D | — · — to — | 10,996.79 Common Stock | (F1) On February 18, 2025, the Company's Compensation and Management Development Committee certified a performance share payout based on the level of the Company's performance relative to pre-established objectives for the January 1, 2022 through December 31, 2024 performance period. The performance shares were paid in shares of the Company's common stock. |
| 9 | Derivative | Stock Option | 2025-02-18 | M | D | 6,732 | $0.00 | 13,462 | D | $48.89 · — to 2027-02-28 | 6,732 Common Stock | (F6) The options became fully exercisable on February 28, 2020, the third anniversary of the grant date. |
| 10 | Derivative | Performance Shares | 2025-02-18 | M | D | 10,996.79 | $0.00 | 0 | D | — · — to — | 10,996.79 Common Stock | (F1) On February 18, 2025, the Company's Compensation and Management Development Committee certified a performance share payout based on the level of the Company's performance relative to pre-established objectives for the January 1, 2022 through December 31, 2024 performance period. The performance shares were paid in shares of the Company's common stock. |